Smarter strategies for comparator drug sourcing in clinical trials
In clinical research, the stability of a study often depends on a single, essential element: reliable access to comparator medications. But drug sourcing is constantly challenged by unpredictable product availability, global logistics hurdles, and shifting regulatory environments such as export bans. To navigate this complexity, pharmaceutical and biotech companies need a strategy that’s not just […]
The post Smarter strategies for comparator drug sourcing in clinical trials appeared first on Medical News Bulletin.